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Abstract
Purpose To examine the psychometric properties of the
9-item Fatigue Severity Scale (FSS) using a Rasch model
application.
Methods A convenience sample of HIV-infected adults
was recruited, and a subset of the sample was assessed at
6-month intervals for 2 years. Socio-demographic, clinical,
and symptom data were collected by self-report question-
naires. CD4 T-cell count and viral load measures were
obtained from medical records. The Rasch analysis inclu-
ded 316 participants with 698 valid questionnaires.
Results FSS item 2 did not advanced monotonically, and
items 1 and 2 did not show acceptable goodness-of-fit to
the Rasch model. A reduced FSS 7-item version demon-
strated acceptable goodness-of-fit and explained 61.2% of
the total variance in the scale. In the FSS-7 item version, no
uniform Differential Item Functioning was found in rela-
tion to time of evaluation or to any of the socio-demo-
graphic or clinical variables.
Conclusion This study demonstrated that the FSS-7 has
better psychometric properties than the FSS-9 in this HIV
sample and that responses to the different items are com-
parable over time and unrelated to socio-demographic and
clinical variables.
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Abbreviations
AIDS Acquired immune deficiency syndrome
BMI Body mass index
DIF Differential item functioning
DS Daytime sleepiness subscale
FSS Fatigue severity scale
GSDS General sleep disturbance scale
HIV Human immunodeficiency virus
PCA Principal component analysis
SE Standard error
Introduction
Fatigue is a distressing and frequent symptom among people
with HIV and is related to lower quality of life [1, 2]. Indi-
viduals describe fatigue as silent and invisible, which can
make it difficult for health care providers to understand how
seriously it impacts patients’ lives [3]. Prevalence estimates
for fatigue range from 37 to 65% [4–7]. Several studies of
people with HIV have found that fatigue is related to
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psychosocial factors such as sleep disturbance [4, 8], depres-
sive symptoms [9, 10], anxiety [9], or post-traumatic stress
[11]. Studies of physiological correlates of fatigue report
conflicting findings about relationships between fatigue and
CD4? T-cell count [12, 13] or viral load [6, 7, 11, 14, 15].
Since fatigue is a subjective phenomenon, researchers
and clinicians rely on subjective measures to indicate need
for intervention or effectiveness of treatment. It is therefore
important to have reliable and valid instruments to measure
fatigue as a symptom that can vary over time or across
illness severity.
The fatigue severity scale
The fatigue severity scale (FSS) [16] is one of the most
frequently used fatigue measures for adults with chronic
illness, including multiple sclerosis [17] and stroke [18]. It
has also been used in studies of people with HIV [10, 19–21]
and in the general population [22]. In a recent published
review of 18 fatigue instruments used in chronic illness
research, the FSS was rated highest on robust psychometric
properties [23]. An important advantage of this instrument is
that it is short and consists of only 9 items. This can be
especially important for people with limited stamina in
completing lengthy questionnaires. Furthermore, normative
data from the general population are available. Clinical cut-
off scores have also been reported, but to our knowledge, the
different cut-off values have not been clinically validated.
The nine items are formulated as statements (see Table 1),
with seven items related to fatigue interference, one item
related to the experience of fatigue itself (item 3), and one
item about what causes fatigue (item 2).
The aim of this study was to examine the psychometric
properties of the FSS in a sample of HIV-infected adults and
to propose a revised version with better psychometric
properties. The specific objectives were to determine: (1) the
fit of the items to the Rasch model and unidimensionality, (2)
person-response validity, (3) reliability, (4) concurrent
validity, and (5) the presence of uniform differential item
functioning (DIF) in relation to time intervals for evaluation,
socio-demographic factors, and clinical variables.
Methods
Data were collected as part of a prospective longitudinal
study of adults with HIV [19]. The study was designed to
characterize the symptom experience of HIV-positive
adults and identify biological and genetic markers of their
symptom experience.
Sample and procedures
A convenience sample of 350 adults with HIV was enrolled in
the study over a 3-year period (April 2005 to December 2007).
The participants were recruited using flyers posted at local
HIV clinics and community sites. Study visits were conducted
at the University of California, San Francisco, Clinical
Research Center. Eligible participants were English-speak-
ing, at least 18 years old, and diagnosed with HIV at least
30 days before enrollment. Individuals were excluded if they
currently used illicit drugs, worked nights, had been pregnant
in the previous 3 months, or reported having a diagnosed
sleep disorder, bipolar disorder, schizophrenia, or dementia.
Data collection and measurements
All participants completed a baseline assessment. Those
not already reporting significant sleep disturbance or
fatigue at baseline were included in a longitudinal study
focused on the development of these symptoms over time
and were assessed at 6-month intervals for up to 2 years,
for a maximum of five assessments each. Self-report
questionnaires were used to collect data on demographics,
Table 1 The fatigue severity
scale (FSS); English (US)
version
A. Items
1. My motivation is lower when I am fatigued
2. Exercise brings on my fatigue
3. I am easily fatigued
4. Fatigue interferes with my physical functioning
5. Fatigue causes frequent problems for me
6. My fatigue prevents sustained physical functioning
7. Fatigue interferes with carrying out certain duties and responsibilities
8. Fatigue is among my three most disabling symptoms
9. Fatigue interferes with my work, family, or social life
B. Response categories on a Likert scale
Strongly disagree Strongly agree
1 2 3 4 5 6 7
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clinical characteristics, and concurrent symptoms. CD4?
T-cell count and viral load measures were obtained from
the most recent laboratory report in their medical record.
Variables used for analysis
The questionnaire included demographic information on
age, gender, race/ethnicity, level of education, partner
status, and employment status. Participants also reported
whether they had ever received a diagnosis of AIDS.
Measures of height and weight were obtained from each
participant and used to calculate body mass index (BMI).
Fatigue during the last week was measured with the
FSS, a 9-item unidimensional questionnaire developed by
Krupp et al. [16] (Table 1). Each item is scored on a
7-point Likert scale ranging from 1 (‘‘strongly disagree’’)
to 7 (‘‘strongly agree’’). The mean score of the 9 items is
used to estimate fatigue severity.
The Daytime Sleepiness (DS) subscale of the General
Sleep Disturbance Scale (GSDS) [24] was used to assess
impact of sleepiness on daytime function. The subscale
consists of 7 symptoms (e.g., struggle to stay awake during
the day). Respondents rate how often they experienced
each item in the past week using a numeric rating scale
ranging from 0 (‘‘no days’’) to 7 (‘‘every day’’). The item
scores are averaged to yield a subscale score ranging from
0 to 7. A score of 3 or higher is used to identify those
experiencing impaired daytime function due to sleepiness
at least 3 days per week. The Cronbach’s alpha coefficient
of the subscale was 0.77 in this sample.
A 4-item numerical rating version of the Visual Analog
Scale for Fatigue [25] was used to prospectively measure
fatigue severity each morning and evening for three con-
secutive days. Because morning fatigue ratings are likely to
be confounded by sleep disturbance, only evening fatigue
was used for this analysis. Each item was rated on a scale
from 0 to 10 and averaged to obtain a mean score for each
person. The Cronbach alpha coefficient of the 4-item
evening fatigue scale was 0.91 in this sample.
Statistical analysis
A Rasch model was chosen to analyze the FSS for two
reasons. First, items in the FSS represent different aspects
of fatigue in everyday life that are assumed to vary in
severity among adults with HIV infection. The Rasch
model takes each item scored and adjusts the final person
measure based on relative differences in item severity.
Secondly, Rasch models are suitable for handling data
where items may be missing at random. Even though only
16 of the 2,844 (0.6%) item scores were missing among the
316 participants, we did not have to exclude any participant
due to missing values by the use of a Rasch model [26–28].
The WINSTEPS analysis software program, version
3.69.1.16 [29], was used to conduct the Rasch analysis.
A Rasch analysis first converts raw item scores from a
questionnaire into equal-interval measures using a loga-
rithmic transformation of the odds probabilities of respon-
ses. These converted values are then used to examine
whether items from a scale measure a unidimensional
construct, viewed as crucial in both classical and modern
test statistics [26, 30]. The transformation simultaneously
results in an estimation of a person’s fatigue measure as
well as difficulty of the items along a calibrated continuum
(from easy to harder to agree with). Rasch models are
probabilistic and based on theoretical assertions against
which the actual pattern of responses is validated. Although
the FSS uses a generic rating scale from 1 to 7, it may not
function in a similar manner across all items. Therefore, a
partial credit model, developed for scales where ratings
may differ across items, was applied to the FSS in this
sample.
The psychometric properties of the rating scale used in
the FSS were initially evaluated (step 1) with the following
criteria: (a) average measures for each step category on each
item should advance monotonically, and (b) a criterion less
than 2.0 was expected in outfit mean square (MnSq) values
for step category calibrations [31, 32]. The fit of the items to
the Rasch model was then analyzed (step 2) followed by
principal component analysis to address unidimensionality
(step 3), aspects of person-response validity (step 4) and
person-separation reliability (step 5). Finally, differential
item functioning (DIF) analyses were performed to further
support the fit of the items to the Rasch model (step 6).
Evidence of internal-scale validity (step 2) and person-
response validity (step 4) were investigated using item and
person goodness-of-fit statistics using the WINSTEPS pro-
gram to generate mean square (MnSq) residuals and stan-
dardized z-values. These indicate the degree of match between
actual responses on the FSS and expected responses from the
Rasch model. The goodness-of-fit statistics were evaluated
using both infit and outfit statistics. Infit statistics are infor-
mation-weighted fit statistics that give relatively more weight
to the performances of persons who are well targeted to the
item difficulty calibrations. Outfit statistics are not weighted
and therefore are more sensitive to outlying scores. As infit
statistics are more informative when exploring the fit of the
items to the Rasch model and person-response validity [33,
34], we chose infit statistics to evaluate goodness-of-fit across
individual items and across persons in this study.
The MnSq fit statistic has an expected value of 1.0 and is
preferable for item goodness-of-fit with polytomous data
(as in the FSS), as it is less sensitive to sample size com-
pared to z [35]. We therefore chose to use a sample size-
adjusted criterion [35] for item goodness-of-fit set for infit
MnSq values between 0.7 and 1.3 logits.
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The final criterion for evaluating person goodness-of-fit
was to accept infit MnSq values B 1.4 logit with an asso-
ciated z value \ 2 [36, 37]. It is generally accepted that 5%
of the sample, by chance, may not demonstrate acceptable
goodness-of-fit without a serious threat to person-response
validity [36, 37].
To minimize risk of additional explanatory factors, a
principal component analysis (PCA) of residuals was per-
formed to evaluate unidimensionality of the FSS (step 3)
[38]. Two criteria were set: (1) at least 50% of the total
variance should be explained by the first latent variable
(perceived fatigue), and (2) any additional factor should
explain \5% of the remaining variance of residuals (with
an associated eigenvalue B 1.4) after removal of the first
latent variable [39, 40].
To further determine whether the FSS could distinguish
people with different levels of fatigue, person-separation
reliability was investigated with the individual and group
standard error (SE) of measures (step 5). For a scale to
distinguish between three or more groups, a person-
separation index of 2.0 is required. For the purpose of
comparison to more traditional reliability estimates, the
Rasch-equivalent Cronbach alpha statistic was also reported.
Initially, an analysis of all 9 FSS items was performed.
If an item did not demonstrate acceptable goodness-of-fit to
the model according to criteria, one item at a time was
removed and psychometric properties were reanalyzed
with the remaining items. This procedure was repeated
until all items demonstrated acceptable goodness-of-fit.
After each item removal, unidimensionality, person-
response validity, and reliability of the FSS measures were
re-evaluated as described above.
A number of differential item functioning (DIF) analyses
were also performed to evaluate stability of response patterns
in relation to repeated time intervals, socio-demographic
factors, and clinical variables (step 6). The magnitude of DIF
was evaluated using the Mantel–Haenszel statistic for
polytomous scales using log-odds estimators [41, 42] in the
WINSTEPS program (1% alpha with Bonferroni correction).
Given the impact of sample size on standard errors of item
difficulty estimates, differences between items could be
artificially significant but not clinically relevant; therefore,
we also evaluated the size of the discrepancy between item
difficulty estimates. This was evaluated using an additional
approach in which the item standard error was set at 0.15
logit, indicating that an item difference must exceed 0.43
logit in order to be clinically relevant [43–45]. For the FSS
items to be considered stable across external variables, no
item should have a significant or clinically relevant DIF.
SPSS for Windows Version 14.0 software (SPSS Inc.,
IL, USA) was used to analyze demographic data, concur-
rent validity, and potential differences in demographic or
clinical variables between persons with and without misfit.
Categorical data were analyzed using chi-square. Concur-
rent validity was assessed by correlations (Spearman’s rho)
between the Rasch generated FSS measures, daytime
sleepiness scores, and evening fatigue severity ratings.
Cronbach alpha coefficients were reported for the daytime
sleepiness scale and the evening fatigue severity scale.
Ethics
The study was approved by the Committee on Human
Research at the University of California, San Francisco. All
participants provided written informed consent.
Results
Sample characteristics
After excluding 34 participants for testing positive for an
illicit drug or having no FSS data, the final sample included
316 participants. Mean age at baseline was 45 years
(SD ± 8.4). The sample characteristics are described in
Table 1. A total of 698 FSS questionnaires were included
in the analysis (316 at baseline, 116 at 6 months, 103 at
12 months, 90 at 18 months, and 73 at 24 months). Initial
analyses were conducted on the baseline sample
(N = 316). To determine whether there was differential
item functioning in relation to multiple time points of
evaluation, the analyses were repeated with the complete
longitudinal (N = 698) as part of step 6 (Table 2).
Rating scale functioning (step 1)
When evaluating rating scale function of the FSS-9 for the
baseline sample, items 1 and 2 did not meet the set criteria.
The average step calibration measures did not advance
monotonically for item 2, and both items were associated
with higher than acceptable outfit MnSq values (Table 3).
The other 7 items demonstrated acceptable values. Anal-
ysis proceeded keeping items 1 and 2 in the FSS to evaluate
further aspects of FSS-9 validity for the HIV population.
The fit of the items to the Rasch model
and unidimensionality (steps 2 and 3)
In the analysis of the 9-item FSS, items 1 and 2 did not
demonstrate acceptable goodness-of-fit. Analysis continued
by removing the item demonstrating the least acceptable
goodness-of-fit (i.e., item 2) and repeating the analysis on
the remaining items. The item removal process continued
until all remaining items had acceptable goodness-of-fit.
Subsequent iterations also removed item 1 (see Table 3),
and the seven remaining items all demonstrated acceptable
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goodness-of-fit. The continuum of difficulty calibrations
for the remaining 7 FSS items is presented in Table 4.
The PCA for the final 7-item FSS version suggests that
the Rasch model aligns with measuring fatigue interfer-
ence. The Rasch model explained 61.2% of the total vari-
ance in the dataset, which was above the 50% criterion and
further supports unidimensionality, in addition to item fit.
The secondary factor explained an additional 8.5% of the
variance, which was slightly higher than the expected 5%.
Therefore, evidence of unidimensionality is still mixed in
the 7-item FSS version.
Person-response validity and reliability (steps 4 and 5)
Of the 316 FSS surveys, 291 (92.1%) demonstrated
acceptable goodness-of-fit to the Rasch model. Person
misfit occurred in 25 persons, and therefore FSS-7 dem-
onstrated a somewhat higher level of misfit among partic-
ipants than expected. A comparison of responses with
misfit and without misfit showed a higher proportion of
persons with misfit scores among black/African Americans
(n = 19, 15.6%) than among Caucasians (n = 5, 3.9%) or
other ethnic groups (n = 1, 1.5%, v = 16.3, P \ 0.001).
The number of participants with maximum and mini-
mum scores (ceiling and floor effects) across the different
FSS item solutions is shown in Table 3. The proportion of
participants demonstrating maximum or minimum scores
was higher for the FSS-7 compared to the FSS-9 version.
The person-separation index in the FSS-7 was 2.341,
indicating that the Rasch model captures fatigue from the
dimension of its impact or interference and can detect more
than three statistically distinct groups of participants within
the sample. The Rasch-equivalent Cronbach alpha coefficient
for the FSS-9 was 0.90, and the alpha for the FSS-7 was 0.92.
In Fig. 1, the distributions of persons’ ability measures
and item calibration values (including each item threshold
Table 2 Demographic and clinical characteristics of the baseline
sample (N = 316)
Variables Total sample N (%)
Demographic variables
Age groups
22–39 years 86 (27.2)
40–49 years 133 (42.1)
50–77 years 97 (30.7)
Gender
Men 216 (68.4)
Women 77 (24.4)
Transgender 23 (7.3)
Race/ethnicity
Black/African American 122 (38.6)
White/Caucasian 129 (40.8)
Other 65 (20.6)
Level of formal education
Some high school or less 47 (14.9)
High school diploma or equivalent 94 (29.7)
Some college 107 (33.9)
College degree or higher 68 (21.5)
Partner status: In a relationship 109 (34.5)
Employment
Not working and not in school 267 (84.5)
Employed or in school 49 (15.5)
Clinical variables
AIDS diagnosis: yes 165 (52.2)
Body mass index (n = 313)
\24.9 131 (41.9)
C25.0 182 (58.1)
CD4? T-cell count (n = 312)
\200 cells/mm3 54 (17.3)
Viral load (n = 294)
C10 000 copies/ml 58 (19.7)
Table 3 Presentation of the outcomes from the first five steps in Rasch analysis of the psychometric properties of the different fatigue severity
scale (FSS) item solutions in adults with HIV infection
Step FSS 9-items
(N = 316)
FSS 8-items
Item 2 removed
(N = 316)
FSS 7-items
Items 1 and 2 removed
(N = 316)
FSS 7-items
Items 1 and 2 removed
(N = 698)
1 Items not meeting criteria
for rating scale
1,2 1 None None
2 Item misfit 1,2 1 None 3
3 Variance explained, % 55.2% 58.9% 61.2% 58.8%
2nd dimension, % 9.0% 8.1% 8.5% 9.1%
4 Person misfit, n (%) 29 (9.2) 25 (7.9) 25 (7.9) 58 (8.3)
Maximum score, n (%) 5 (1.6) 10 (3.2) 10 (3.2) 14 (2.0)
Minimum score, n (%) 18 (5.7) 19 (6.0) 26 (8.2) 75 (10.7)
5 Person-separation index
(without extremes)
2.09 2.24 2.31 2.08
Qual Life Res (2011) 20:1447–1456 1451
123
per category score) are presented. Most of the fatigue
interference among clients with HIV was captured within
the FSS-7 version, despite earlier mentioned ceiling and
floor effects (see also Table 3).
Presence of uniform DIF in the FSS-7 in relation
to demographic factors, clinical variables, and multiple
time points of evaluation (step 6)
There was no uniform DIF among the 7 items by age groups
in the baseline sample (22–39, 40–49, 50–77 years), gender
(men, women, transgender), employment (yes, no), or part-
ner status (in a relationship or not). Item 7 demonstrated
significant uniform DIF in relation to race/ethnicity (black/
African American, white/Caucasian, other), but it was not a
clinically relevant difference. Items 5, 7, and 8 also dem-
onstrated significant uniform DIF for level of education
(some high school or less, high school diploma or equivalent,
some college, college degree or higher), but again differ-
ences were not clinically relevant. There was also no uniform
DIF among any clinical variable (i.e. AIDS diagnosis [yes,
no], BMI [\24.9 C 25.0], CD4? T-cell count [\200 cells/
mm3, C200 cells/mm3], viral load [\10,000 copies/ml,
C10,000 copies/ml]). With no evidence of relevant clinical
differences, the uniform DIF in the FSS-7 did not require
further action (e.g., item split techniques).
To ensure that the findings in relation to aspects of
validity in the FSS-7 were stable even when including
multiple measures per person, we repeated all Rasch
analyses of the FSS-7 using data from all available time-
points (n = 698) (see Table 3). Because no notable dif-
ferences were observed between analyses with the 698
records and the 316 independent baseline measures, it was
concluded that no items in the FSS-7 demonstrated uniform
DIF in relation to multiple time points of evaluation.
Concurrent validity
Adequate concurrent validity was demonstrated with
bivariate relationships at baseline (N = 316) between the
FSS the Daytime Sleepiness subscale from the GSDS;
Spearman’s rho = 0.53 for the FSS-7 and rho = 0.52 for
the FSS-9. The Spearman’s correlation coefficient between
FSS and evening fatigue was 0.37 for the FSS-7 and 0.38
for the FSS-9.
Discussion
Results of this Rasch analysis suggest that a 7-item FSS has
better psychometric properties, overall, than the original
9-item FSS for adults living with HIV. The FSS-7 has
satisfactory fit of the items to the Rasch model, stable
response patterns over time, no uniform DIF in relation to
any clinical variables, and no clinically relevant DIF in
relation to any of the socio-demographic variables. The
items in the FSS-7 are all statements related to fatigue’s
interference with daily functioning, since items related to
the cause for fatigue and experience of fatigue were
excluded in the FSS-7. Thus, we conclude that the FSS-7
measures fatigue interference or impact as a unidimen-
sional concept. Several other studies have tested the uni-
dimentionallity of the FSS-9 and concluded that it is a
unidimensional scale [23, 46]. Since fatigue is theoretically
understood as a multi-dimensional concept [47, 48],
including dimensions such as distress, and mental and
physical fatigue [47, 49], future studies of fatigue associ-
ated with HIV infection should use different measures in
order to capture its different dimensions (Whitehead 2009).
Like the FSS-9, the explained variance of the latent vari-
able in the FSS-7 was satisfactory, although for both the
FSS-7 and the FSS-9, the proportion of variance explained
by the second dimension was above the expected 5%.
Results from this study are fairly consistent with those
of two recent psychometric studies evaluating the FSS
among people with multiple sclerosis using Rasch analysis
[50, 51]. Due to inconsistent responding patterns, both
studies concluded that exclusion of items 1 and 2 would
improve the fit of the items to the Rasch model. In our
Table 4 FSS-7 item hierarchy
for adults with HIV infection
Measure (logit) SE (logit) Item
Harder to agree with 0.30 0.05 Item 5: Fatigue causes frequent problems for me
0.17 0.05 Item 6: My fatigue prevents sustained physical
functioning
0.13 0.05 Item 3: I am easily fatigued
0.03 0.05 Item 7: Fatigue interferes with carrying out certain
duties and responsibilities
-0.02 0.05 Item 9: Fatigue interferes with my work, family, or
social life
-0.16 0.05 Item 8: Fatigue is among my three most disabling
symptoms
Easier to agree with -0.47 0.05 Item 4: Fatigue interferes with my physical functioning
 






!
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sample of adults with HIV, no additional items had to be
excluded in order to meet criteria of item fit. [51]. Based on
findings from these studies, we conclude that in order to
measure fatigue’s impact or interference with a valid
measure across different diagnostic groups, items 1 and 2
should always be excluded from calculation of the mean
    More fatigue interference 
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          | 
                  .  | 
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Fig. 1 Item/Person map with
FSS-7 with each item category
threshold calibration value (1–2,
2–3, 3–4, 4–5, 5–6, and 6–7)
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score, but additional items to be excluded may vary by type
of clinical population.
The item hierarchy for the FSS-7 demonstrated a stable
pattern over time for the HIV sample and provides support
for the validity of comparisons over time. When analysis of
all time points was repeated and findings were replicated
with an analysis of baseline data only, use of repeated
measures did not impact our final conclusions regarding
validity of the FSS-7.
When evaluating the item hierarchy of the FSS, item 4
(‘‘fatigue interferes with my physical functioning’’) and
item 8 (‘‘fatigue is among my three most disabling symp-
toms’’) were the items most easily agreed with, while item
5 (‘‘fatigue causes frequent problems for me’’) was the
most difficult for subjects to agree with. Among the seven
items in the FSS-7, item 8 is the most general and abstract
statement. Thus, adults with HIV in our sample found it
relatively easy to report fatigue as one of their most dis-
abling symptoms. This may reflect the significant impact
fatigue has on quality of life, even considering the many
other symptoms they experience [52]. To understand
whether this finding is unique to the HIV population,
additional research is needed to determine whether similar
item hierarchies and distributions along the continuum of
fatigue are observed in other clinical populations.
The mixed findings regarding unidimensionality of both
the FSS-9 and FSS-7 suggest that additional consideration
be given to what the scale actually measures. Fatigue is still
a poorly defined construct for persons with HIV/AIDS, and
some FSS items address impact of fatigue or how it
interferes with daily activity rather than fatigue severity.
While these concepts are likely strongly related, it is pos-
sible to imagine instances in which they might differ. For
example, people with demanding lives and multiple roles
may find that the same fatigue severity has a greater impact
on their lifestyle than someone with fewer social, occu-
pational, or other demands. Further studies are needed to
explore and define the construct of fatigue interference for
this sample, using a variety of both qualitative and quan-
titative approaches.
Our study showed that black/African Americans in the
sample were more likely to have misfit, indicating that this
group might experience fatigue in a systematically different
way from other ethnic groups. Previous studies [52, 53]
suggest that black/African Americans may report less
symptom burden than expected, possibly due to genetic,
socio-cultural, or spiritual factors. A recent published study
[51] reported DIF of some of the FSS items between a
Norwegain and a Swedish cohort. Future studies should
evaluate potential DIF in relation to race/ethnicity, possibly
using item split techniques to make valid comparisons
between groups and assess whether these differences have
any clinical relevance. Why race/ethnicity would result in
differences with the FSS or how race/ethnicity would
interact with other socio-demographic and clinical variables
would require larger groups for more in-depth analyses.
Both FSS-9 and FSS-7 had high estimates of internal
consistency assessed with Cronbach’s alpha. However, our
Rasch analysis was able to detect problems with unidi-
mensionality that the Cronbach alpha coefficients could
not. Future studies should therefore be more cautious in the
use and interpretation of Cronbach alpha coefficients in
relation to aspects of validity of clinical assessments. The
bivariate analysis assessing concurrent validity of the FSS-
7 showed low to moderate correlations and indicated that
the FSS-7 measure of fatigue interference is related to, but
not the same as Daytime Sleepiness or evening fatigue
severity. Different definitions, assessments, and approaches
should therefore be used in order to target the clinically
relevant aspect of fatigue addressed. The relationships
between such different aspects must however in the future
be both theoretically clarified and empirically tested. The
outcomes of this study indicate that the FSS-7 could be
used in a valid manner to measure and compare groups of
adults living with HIV with variations in how fatigue
impacts or interferes with functioning over time and across
socio-demographics and clinical variables without any
threat to validity.
This study had a number of limitations. First, the sample
used in this study was a convenience sample and may not be
representative of the larger population of adults living with
HIV. Second, the analysis of differential item functioning in
relation to multiple time points was limited by the sub-
sequent exclusion of participants reporting sleep distur-
bance or fatigue at their baseline measures. This limitation
was a characteristic of the original study, but future studies
should include multiple measurements from participants
experiencing the full range of fatigue symptoms.
Conclusion
The 7-item version of the FSS derived from the Rasch
analysis had better psychometric properties than the FSS-9
in this sample of adults living with HIV infection. With
fewer items, it remains a valid and reliable measure of
fatigue, while losing very little of the descriptive power of
the FSS-9. However, additional research is needed to
determine whether these findings are consistent across
clinical population, across culture or race/ethnicity, and
across other relevant demographic and clinical variables.
Since the FSS has been rated one of the best fatigue
measures in terms of its psychometric properties, results
from this study suggest that other symptoms and quality of
life measures might benefit from further examination using
a Rasch model as well.
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